Riskpilot← Back to searchSign inGet full accessVaccination Mölndalsbro AB
ABDissolvedOrg 5569504441Economic activity was not specified by tax authority · NACE 0000Est. 20130 employees
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +0% |
| Net profit | SEK 0 | — |
| Total assets | SEK 52K | +0% |
| Equity | SEK 52K | +0% |
| Employees | 0 | — |
Legal name
Vaccination Mölndalsbro AB
Org number
5569504441
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
26 november 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet skall vara att bedriva vaccinationsverksamhet, övrig sjuk- och hälsovård, äga och förvalta värdepapper och fast egendom samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −12 | −13 | −3 | −2 | −2 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | −12 | −13 | −3 | −2 | −2 |
| Net financials | 12 | 13 | 3 | 2 | 2 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | — | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 62 | 62 | 52 | 52 | 52 |
| Equity | 52 | 52 | 52 | 52 | 52 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 10 | 10 | 0 | 0 | 0 |
| Total debt | 10 | 10 | — | — | — |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
LM Audit | Audit | 2022 |
CM Chief Executive Officer | Chief Executive Officer | 2022 |
SV Auditor Substitute | Auditor Substitute | 2022 |
| Former (1) | ||
BR Audit | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doctorum AB
Vaccination Mölndalsbro AB Board members of Vaccination Mölndalsbro AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Frisk | Audit | 0 companies |
| Bengt Rune Attsell | Audit | 0 companies |
| Cornel Mihai Popa | Chief Executive Officer | 0 companies |
| Stefan Valdemar Freij | Auditor Substitute | 0 companies |
| Per Arne Kristian Liff | Board of Directors | 0 companies |
| John Ted Wulcan | Chairman | 0 companies |
| Ingela Veronica Sager | Deputy Board Member | 0 companies |
| Johan Sager | Board of Directors | 0 companies |
| Ulf Roine Pettersson | Deputy Board Member | 0 companies |
| Anna-Karin Elisabeth Hedman | Chairman | 0 companies |